Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis X Hou, X Zhang, W Zhao, C Zeng, B Deng, DW McComb, S Du, C Zhang, ... Nature nanotechnology 15 (1), 41-46, 2020 | 224 | 2020 |
Long-term storage of lipid-like nanoparticles for mRNA delivery P Zhao, X Hou, J Yan, S Du, Y Xue, W Li, G Xiang, Y Dong Bioactive materials 5 (2), 358-363, 2020 | 216 | 2020 |
Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin H Xiong, S Du, J Ni, J Zhou, J Yao Biomaterials 94, 70-83, 2016 | 199 | 2016 |
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing X Zhang, W Zhao, GN Nguyen, C Zhang, C Zeng, J Yan, S Du, X Hou, ... Science advances 6 (34), eabc2315, 2020 | 167 | 2020 |
Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy JQ Liu, C Zhang, X Zhang, J Yan, C Zeng, F Talebian, K Lynch, W Zhao, ... Journal of Controlled Release 345, 306-313, 2022 | 150 | 2022 |
Leveraging mRNA sequences and nanoparticles to deliver SARS‐CoV‐2 antigens in vivo C Zeng, X Hou, J Yan, C Zhang, W Li, W Zhao, S Du, Y Dong Advanced Materials 32 (40), 2004452, 2020 | 145 | 2020 |
Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy W Li, X Zhang, C Zhang, J Yan, X Hou, S Du, C Zeng, W Zhao, B Deng, ... Nature Communications 12 (1), 7264, 2021 | 88 | 2021 |
Attempts to strengthen and simplify the tumor vascular normalization strategy using tumor vessel normalization promoting nanomedicines S Du, H Xiong, C Xu, Y Lu, J Yao Biomaterials science 7 (3), 1147-1160, 2019 | 52 | 2019 |
STING agonist-derived LNP-mRNA vaccine enhances protective immunity against SARS-CoV-2 Y Zhang, J Yan, X Hou, C Wang, DD Kang, Y Xue, S Du, B Deng, ... Nano letters 23 (7), 2593-2600, 2023 | 49 | 2023 |
Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy Y Zhang, X Hou, S Du, Y Xue, J Yan, DD Kang, Y Zhong, C Wang, B Deng, ... Nature nanotechnology 18 (11), 1364-1374, 2023 | 45 | 2023 |
Adoptive cell therapy for cancer treatment S Du, J Yan, Y Xue, Y Zhong, Y Dong Exploration 3 (4), 20210058, 2023 | 44 | 2023 |
Primary tumor and pre-metastatic niches co-targeting “peptides-lego” hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment H Xiong, S Du, P Zhang, Z Jiang, J Zhou, J Yao Biomaterials Science 6 (10), 2591-2604, 2018 | 43 | 2018 |
Cholesterol‐Amino‐Phosphate (CAP) derived lipid nanoparticles for delivery of self‐amplifying RNA and restoration of spermatogenesis in infertile mice S Du, W Li, Y Zhang, Y Xue, X Hou, J Yan, J Cheng, B Deng, ... Advanced science 10 (11), 2300188, 2023 | 36 | 2023 |
Nanomaterials‐mediated co‐stimulation of toll‐like receptors and CD40 for antitumor immunity J Yan, Y Zhang, S Du, X Hou, W Li, C Zeng, C Zhang, J Cheng, B Deng, ... Advanced Materials 34 (47), 2207486, 2022 | 34 | 2022 |
LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing Y Xue, Y Zhang, Y Zhong, S Du, X Hou, W Li, H Li, S Wang, C Wang, ... Nature Communications 15 (1), 739, 2024 | 33 | 2024 |
LMWH and its derivatives represent new rational for cancer therapy: construction strategies and combination therapy S Du, Y Yu, C Xu, H Xiong, S Yang, J Yao Drug discovery today 24 (10), 2096-2104, 2019 | 32 | 2019 |
mRNA delivery in cancer immunotherapy Y Zhong, S Du, Y Dong Acta Pharmaceutica Sinica B 13 (4), 1348-1357, 2023 | 26 | 2023 |
Computational and experimental approaches to investigate lipid nanoparticles as drug and gene delivery systems C Chan, S Du, Y Dong, X Cheng Current topics in medicinal chemistry 21 (2), 92-114, 2021 | 26 | 2021 |
Emerging role of interactions between tumor angiogenesis and cancer stem cells S Lv, Y Liu, C Xie, C Xue, S Du, J Yao Journal of Controlled Release 360, 468-481, 2023 | 19 | 2023 |
Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy Y Xiao, C Xu, H Xiong, S Du, J Zhou, L Yin, J Yao European Journal of Pharmaceutical Sciences 119, 121-134, 2018 | 16 | 2018 |